AlmirallLBTSF 85 Gross Margin % is 64.33% as of Mar. 2026, which is 18% below its 10-year median of 78.53. GuruFocus rates LBTSF with a GF Score™ of 85/100 and a GF Value™ of $16.92. The stock has 4 warning signs investors should review. Among 938 Drug Manufacturers companies, Almirall ranks better than 81.56% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Almirall's Gross Profit for the
three
months ended in Mar. 2026 was $217 Mil. Almirall's Revenue for the
three
months ended in Mar. 2026 was $338 Mil. Therefore, Almirall's Gross Margin % for the quarter that ended in Mar. 2026 was 64.33%.
The historical rank and industry rank for Almirall's Gross Margin % or its related term are showing as below:
LBTSF'
s Gross Margin % Range Over the Past 10 Years
Min: 69.76 Med: 78.53 Max: 89.11
Current: 69.76
During the past 13 years, the highestGross Margin % of Almirall was 89.11%. The lowest was 69.76%. And the median was 78.53%.
LBTSF's Gross Margin % is ranked better than 81.56% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.44
vs LBTSF: 69.76
Almirall had a gross margin of 64.33% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Almirall was -0.20% per year.
Almirall (OTCPK:LBTSF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Almirall had a gross margin of 64.33% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Almirall Gross Margin % Related Terms
Almirall Gross Margin % Historical Data
* Premium members only.
The historical data trend for Almirall's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LBTSF vs ZTS, UTHR, VTRS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Almirall Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Almirall's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Almirall's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Almirall (LBTSF) has a Gross Margin % of 64.33% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Almirall and its competitors. This is 18% below median its historical median of 78.53. Over the past decade, Almirall's Gross Margin % has ranged from 69.76 to 89.11. According to the industry distribution chart, Almirall ranks #173 out of 938 companies in the Drug Manufacturers industry, placing it in the top 18.4%.
Is Almirall's Gross Margin % too high?
Almirall's current Gross Margin % of 64.33% is 18% below median its 10-year median of 78.53. Over the past 10 years, this metric has ranged from a low of 69.76 to a high of 89.11. The Drug Manufacturers industry median Gross Margin % is 48.44. Almirall's value of 64.33% is 32.8% above this industry median. Based on the distribution chart, Almirall ranks #173 out of 938 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Almirall has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Almirall's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Almirall ranks #173 out of 938 companies for Gross Margin %. This places Almirall in the top 18% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.44. Almirall's value of 64.33% is 32.8% above this benchmark. Historically, Almirall's own Gross Margin % has ranged from 69.76 to 89.11 over the past decade. While the company's 10-year median is 78.53 vs. the industry median of 48.44, Almirall has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Almirall's current Gross Margin % of 64.33% is 32.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Almirall and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Almirall's current Gross Margin % is 64.33%, which is 18% below median its own 10-year median of 78.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almirall stock overvalued right now?
Almirall (LBTSF) has a current Gross Margin % of 64.33%. The stock's GF Value™ is $16.92, compared to a current price of $15.35 — trading 9.3% below its estimated fair value. The current Gross Margin % is 64.33%, which is 18% below median its 10-year median of 78.53 and 32.8% above the Drug Manufacturers industry median of 48.44. Almirall's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Almirall (LBTSF), the current Gross Margin % is 64.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Almirall (LBTSF) Overvalued in 2026?
Based on GuruFocus' analysis, Almirall stock appears to be undervalued.
The current stock price of $15.35 is trading 9.3% below its estimated GF Value™ of $16.92.
Key valuation signals for LBTSF:
Gross Margin %: 64.33% (18% below median its 10-year median of 78.53)
GF Value™: $16.92 vs. price of $15.35 (9.3% below fair value)
Industry Position: 32.8% above the Drug Manufacturers median (#173 of 938)
No single metric tells the full story. See the LBTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
85GF Score
Get the complete analysis for LBTSF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LBTSF has been successfully added to your 
